Chonglin Luo
Overview
Explore the profile of Chonglin Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu J, Yu Y, Zhang S, Zhang P, Yu S, Li W, et al.
Transl Gastroenterol Hepatol
. 2024 Feb;
9:5.
PMID: 38317746
Background: Immune checkpoint inhibitors (ICIs) have significant clinical benefit for a subset of patients with gastrointestinal cancers (GICs) including esophageal cancer, gastric cancer and colorectal cancer. However, it is difficult...
2.
Li Y, Mo S, Zhang L, Ma X, Hu X, Huang D, et al.
Eur J Cancer
. 2022 May;
169:198-209.
PMID: 35636041
Background: Precise methods for risk stratification to guide adjuvant chemotherapy for stage III colon cancers are needed. Here, we combined circulating tumor DNA (ctDNA) with consensus molecular subtype (CMS) to...
3.
Lv N, Hao S, Luo C, Abukiwan A, Hao Y, Gai F, et al.
Sci China Life Sci
. 2018 Jan;
61(5):541-549.
PMID: 29307109
Late-stage melanoma is refractory to current therapies. MicroRNAs (miRNAs) can modulate many physiological and pathological processes of melanoma. Studies have demonstrated that miR-137 acts as a tumor suppressor by inhibiting...
4.
Weber C, Luo C, Hotz-Wagenblatt A, Gardyan A, Kordass T, Holland-Letz T, et al.
Cancer Res
. 2016 May;
76(12):3562-71.
PMID: 27197185
Determinants of invasion and metastasis in cancer remain of great interest to define. Here, we report the definition of miR-339-3p as a novel tumor suppressive microRNA that blocks melanoma cell...
5.
Yang S, Luo C, Gu Q, Xu Q, Wang G, Sun H, et al.
Oncotarget
. 2015 Dec;
7(5):5461-9.
PMID: 26701727
Hepatocellular carcinoma (HCC) is the fifth most common type of cancers worldwide. However, current therapeutic approaches for this epidemic disease are limited, and its 5-year survival rate hasn't been improved...
6.
Hao S, Luo C, Abukiwan A, Wang G, He J, Huang L, et al.
Exp Dermatol
. 2015 Jul;
24(12):947-52.
PMID: 26186482
MicroRNAs (miRNA) are key players in a variety of cancers including malignant melanoma. miR-137 has been reported to be a tumor suppressor in melanoma and several targets have been identified...
7.
Luo C, Weber C, Osen W, Bosserhoff A, Eichmuller S
Eur J Cell Biol
. 2014 Mar;
93(1-2):11-22.
PMID: 24602414
Melanoma is the most dangerous form of skin cancer, being largely resistant to conventional therapies at advanced stages. Understanding the molecular mechanisms behind this disease might be the key for...
8.
Luo C, Merz P, Chen Y, Dickes E, Pscherer A, Schadendorf D, et al.
Cancer Lett
. 2013 Aug;
341(2):240-7.
PMID: 23962556
The microRNA miR-101 has been reported to be a tumor suppressor. Here we show that low expression of miR-101 is associated with poor survival in stage IV melanoma patients. We...
9.
Chen Y, Cao L, Luo C, Ditzel D, Peter J, Sprengel R
Mol Ther Nucleic Acids
. 2013 Apr;
2:e85.
PMID: 23571608
We developed a single vector recombinant adeno-associated viral (rAAV) expression system for spatial and reversible control of polycistronic gene expression. Our approach (i) integrates the advantages of the tetracycline (Tet)-controlled...
10.
Luo C, Tetteh P, Merz P, Dickes E, Abukiwan A, Hotz-Wagenblatt A, et al.
J Invest Dermatol
. 2012 Nov;
133(3):768-775.
PMID: 23151846
MicroRNAs are small noncoding RNAs that regulate gene expression and have important roles in various types of cancer. Previously, miR-137 was reported to act as a tumor suppressor in different...